248 related articles for article (PubMed ID: 16785507)
1. Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO.
Belladonna ML; Grohmann U; Guidetti P; Volpi C; Bianchi R; Fioretti MC; Schwarcz R; Fallarino F; Puccetti P
J Immunol; 2006 Jul; 177(1):130-7. PubMed ID: 16785507
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes.
Belladonna ML; Puccetti P; Orabona C; Fallarino F; Vacca C; Volpi C; Gizzi S; Pallotta MT; Fioretti MC; Grohmann U
Transplantation; 2007 Jul; 84(1 Suppl):S17-20. PubMed ID: 17632406
[TBL] [Abstract][Full Text] [Related]
3. Toward the identification of a tolerogenic signature in IDO-competent dendritic cells.
Orabona C; Puccetti P; Vacca C; Bicciato S; Luchini A; Fallarino F; Bianchi R; Velardi E; Perruccio K; Velardi A; Bronte V; Fioretti MC; Grohmann U
Blood; 2006 Apr; 107(7):2846-54. PubMed ID: 16339401
[TBL] [Abstract][Full Text] [Related]
4. Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond.
Orabona C; Grohmann U
Methods Mol Biol; 2011; 677():269-80. PubMed ID: 20941617
[TBL] [Abstract][Full Text] [Related]
5. Tolerogenic Phenotype of IFN-γ-Induced IDO+ Dendritic Cells Is Maintained via an Autocrine IDO-Kynurenine/AhR-IDO Loop.
Li Q; Harden JL; Anderson CD; Egilmez NK
J Immunol; 2016 Aug; 197(3):962-70. PubMed ID: 27316681
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells.
Belladonna ML; Volpi C; Bianchi R; Vacca C; Orabona C; Pallotta MT; Boon L; Gizzi S; Fioretti MC; Grohmann U; Puccetti P
J Immunol; 2008 Oct; 181(8):5194-8. PubMed ID: 18832670
[TBL] [Abstract][Full Text] [Related]
7. The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.
Shibata Y; Hara T; Nagano J; Nakamura N; Ohno T; Ninomiya S; Ito H; Tanaka T; Saito K; Seishima M; Shimizu M; Moriwaki H; Tsurumi H
PLoS One; 2016; 11(1):e0146279. PubMed ID: 26727596
[TBL] [Abstract][Full Text] [Related]
8. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement.
Fallarino F; Asselin-Paturel C; Vacca C; Bianchi R; Gizzi S; Fioretti MC; Trinchieri G; Grohmann U; Puccetti P
J Immunol; 2004 Sep; 173(6):3748-54. PubMed ID: 15356121
[TBL] [Abstract][Full Text] [Related]
9. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.
Hwu P; Du MX; Lapointe R; Do M; Taylor MW; Young HA
J Immunol; 2000 Apr; 164(7):3596-9. PubMed ID: 10725715
[TBL] [Abstract][Full Text] [Related]
10. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.
Boasso A; Herbeuval JP; Hardy AW; Winkler C; Shearer GM
Blood; 2005 Feb; 105(4):1574-81. PubMed ID: 15466932
[TBL] [Abstract][Full Text] [Related]
11. Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells.
López AS; Alegre E; LeMaoult J; Carosella E; González A
Mol Immunol; 2006 Jul; 43(14):2151-60. PubMed ID: 16490253
[TBL] [Abstract][Full Text] [Related]
12. SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis.
Orabona C; Pallotta MT; Volpi C; Fallarino F; Vacca C; Bianchi R; Belladonna ML; Fioretti MC; Grohmann U; Puccetti P
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20828-33. PubMed ID: 19088199
[TBL] [Abstract][Full Text] [Related]
13. Indoleamine 2,3-dioxygenase in transplantation.
Mulley WR; Nikolic-Paterson DJ
Nephrology (Carlton); 2008 Jun; 13(3):204-11. PubMed ID: 18221253
[TBL] [Abstract][Full Text] [Related]
14. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
[TBL] [Abstract][Full Text] [Related]
15. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions.
Onodera T; Jang MH; Guo Z; Yamasaki M; Hirata T; Bai Z; Tsuji NM; Nagakubo D; Yoshie O; Sakaguchi S; Takikawa O; Miyasaka M
J Immunol; 2009 Nov; 183(9):5608-14. PubMed ID: 19843945
[TBL] [Abstract][Full Text] [Related]
16. Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.
Manlapat AK; Kahler DJ; Chandler PR; Munn DH; Mellor AL
Eur J Immunol; 2007 Apr; 37(4):1064-71. PubMed ID: 17343295
[TBL] [Abstract][Full Text] [Related]
17. Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.
Xu SQ; Wang CY; Zhu XJ; Dong XY; Shi Y; Peng J; Qin P; Sun JZ; Guo C; Ni H; Hou M
Ann Hematol; 2012 Oct; 91(10):1623-31. PubMed ID: 22526360
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant.
Orabona C; Belladonna ML; Vacca C; Bianchi R; Fallarino F; Volpi C; Gizzi S; Fioretti MC; Grohmann U; Puccetti P
J Immunol; 2005 Jun; 174(11):6582-6. PubMed ID: 15905495
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis.
Criado G; Simelyte E; Inglis JJ; Essex D; Williams RO
Arthritis Rheum; 2009 May; 60(5):1342-51. PubMed ID: 19404944
[TBL] [Abstract][Full Text] [Related]
20. Regulation of expression and function of IDO in human dendritic cells.
Heitger A
Curr Med Chem; 2011; 18(15):2222-33. PubMed ID: 21517757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
